Cost-effectiveness analysis of universal mass vaccination with Rotarix® in the Philippines

Lee I-Heng; Standaert Baudouin; Nievera Maria Carmen; Rogacion Jossie; I-Heng Lee; Baudouin Standaert; Maria-Carmen Nievera; Jossie Rogacion.
Pediatric Infectious Disease Society of the Philippines Journal ; : 15-29, 2014.
Artículo en Inglés | WPRIM | ID: wpr-632613

Documentos relacionados

  1. Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status.
  2. Pharmacoeconomic and epidemiological bases of optimal rotavirus vaccine supply for Ukrainian population.
  3. Rotavirus Vaccine Is Effective Against Rotavirus Gastroenteritis Resulting in Outpatient Care: Results From the Medically Attended Acute Gastroenteritis (MAAGE) Study.
  4. Post-Rotavirus Vaccine Enteropathogen Landscape.
  5. Rotavirus vaccination impact, Ireland, implications for vaccine confidence and screening.
  6. Rates and determinants of Rotavirus vaccine uptake among children in Italy: a cross-sectional study within the 2022 OBVIOUS* project.
  7. Correlates of immune protection against human rotaviruses: natural infection and vaccination.
  8. Investigating association between inflammatory bowel disease and rotavirus vaccination in a paediatric cohort in the UK.
  9. Effectiveness of self-financed rotavirus vaccines on acute gastroenteritis primary care episodes using real-world data in Spain: a propensity score-matched analysis of cohort study.
  10. Rotavirus infection in children in Southeast Asia 2008-2018: disease burden, genotype distribution, seasonality, and vaccination.